Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Guidelines Medicine & Life Sciences
Adjuvant Chemotherapy Medicine & Life Sciences
Recurrence Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2017

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients

Rosenstock, A. S., Niu, J., Giordano, S. H., Zhao, H., Wolff, A. C. & Chavez-Macgregor, M. Jan 1 2017 (Accepted/In press) In : Cancer.

Research output: Research - peer-reviewArticle

Myelodysplastic Syndromes
Adjuvant Chemotherapy
Acute Myeloid Leukemia
Health Services
Breast Neoplasms

Combination epigenetic therapy in advanced breast cancer with 5-azacitidine and entinostat: A phase II national cancer institute/stand up to cancer study

Connolly, R. M. , Li, H. , Jankowitz, R. C. , Zhang, Z. , Rudek, M. A. , Jeter, S. C. , Slater, S. A. , Powers, P. , Wolff, A. C. , Fetting, J. H. , Brufsky, A. , Piekarz, R. , Ahuja, N. , Laird, P. W. , Shen, H. , Weisenberger, D. J. , Cope, L. , Herman, J. G. , Somlo, G. , Garcia, A. A. & 5 others Jones, P. A., Baylin, S. B., Davidson, N. E., Zahnow, C. A. & Stearns, V. Jun 1 2017 In : Clinical Cancer Research. 23, 11, p. 2691-2701 11 p.

Research output: Research - peer-reviewArticle

Azacitidine
National Cancer Institute (U.S.)
Epigenomics
Breast Neoplasms
Neoplasms

Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial

Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Di Cosimo, S., Azim, H. A., Fumagalli, D., Sarp, S., Wolff, A. C., Andersson, M., Kroep, J., Cufer, T., Simon, S. D., Salman, P., Toi, M., Harris, L., Gralow, J., Keane, M., Moreno-Aspitia, A., Piccart-Gebhart, M. & De Azambuja, E. May 1 2017 In : Journal of Clinical Oncology. 35, 13, p. 1421-1429 9 p.

Research output: Research - peer-reviewArticle

Metformin
Insulin
Breast Neoplasms
human ERBB2 protein
Disease-Free Survival

Individualized Molecular Analyses Guide Efforts (IMAGE): A prospective study of molecular profiling of tissue and blood in metastatic triple-negative breast cancer

Parsons, H. A. , Beaver, J. A. , Cimino-Mathews, A. , Ali, S. M. , Axilbund, J. , Chu, D. , Connolly, R. M. , Cochran, R. L. , Croessmann, S. , Clark, T. A. , Gocke, C. D. , Jeter, S. C. , Kennedy, M. R. , Lauring, J. , Lee, J. , Lipson, D. , Miller, V. A. , Otto, G. A. , Rosner, G. L. , Ross, J. S. & 10 others Slater, S., Stephens, P. J., Vandenberg, D. A., Wolff, A. C., Young, L. E., Zabransky, D. J., Zhang, Z., Zorzi, J., Stearns, V. & Park, B. H. Jan 15 2017 In : Clinical Cancer Research. 23, 2, p. 379-386 8 p.

Research output: Research - peer-reviewArticle

Triple Negative Breast Neoplasms
Prospective Studies
Neoplasms
Biopsy
Therapeutics

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer

Rimawi, M. F. , de Angelis, C. , Contreras, A. , Pareja, F. , Geyer, F. C. , Burke, K. A. , Herrera, S. , Wang, T. , Mayer, I. A. , Forero, A. , Nanda, R. , Goetz, M. P. , Chang, J. C. , Krop, I. E. , Wolff, A. C. , Pavlick, A. C. , Fuqua, S. A. W. , Gutierrez, C. , Hilsenbeck, S. G. , Li, M. M. & 4 others Weigelt, B., Reis-Filho, J. S., Kent Osborne, C. & Schiff, R. Nov 7 2017 (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-10 10 p.

Research output: Research - peer-reviewArticle

Breast Neoplasms
Drug Therapy
Mutation
Trastuzumab
lapatinib